ACHV
Price
$4.88
Change
+$0.33 (+7.25%)
Updated
Dec 3 closing price
Capitalization
259.78M
98 days until earnings call
Intraday BUY SELL Signals
ATNM
Price
$1.45
Change
+$0.07 (+5.07%)
Updated
Dec 3 closing price
Capitalization
45.23M
99 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACHV vs ATNM

Header iconACHV vs ATNM Comparison
Open Charts ACHV vs ATNMBanner chart's image
Achieve Life Sciences
Price$4.88
Change+$0.33 (+7.25%)
Volume$746.17K
Capitalization259.78M
Actinium Pharmaceuticals
Price$1.45
Change+$0.07 (+5.07%)
Volume$151.03K
Capitalization45.23M
ACHV vs ATNM Comparison Chart in %
ACHV
Daily Signal:
Gain/Loss:
ATNM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACHV vs. ATNM commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACHV is a Hold and ATNM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ACHV: $4.56 vs. ATNM: $1.37)
Brand notoriety: ACHV and ATNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACHV: 19% vs. ATNM: 27%
Market capitalization -- ACHV: $247.27M vs. ATNM: $42.74M
ACHV [@Biotechnology] is valued at $247.27M. ATNM’s [@Biotechnology] market capitalization is $42.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACHV’s FA Score shows that 0 FA rating(s) are green whileATNM’s FA Score has 0 green FA rating(s).

  • ACHV’s FA Score: 0 green, 5 red.
  • ATNM’s FA Score: 0 green, 5 red.
According to our system of comparison, ACHV is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACHV’s TA Score shows that 4 TA indicator(s) are bullish while ATNM’s TA Score has 5 bullish TA indicator(s).

  • ACHV’s TA Score: 4 bullish, 5 bearish.
  • ATNM’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, ATNM is a better buy in the short-term than ACHV.

Price Growth

ACHV (@Biotechnology) experienced а -0.65% price change this week, while ATNM (@Biotechnology) price change was -2.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

ACHV is expected to report earnings on Mar 12, 2026.

ATNM is expected to report earnings on Mar 13, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACHV($260M) has a higher market cap than ATNM($45.2M). ACHV YTD gains are higher at: 29.545 vs. ATNM (8.730). ATNM has higher annual earnings (EBITDA): -43.43M vs. ACHV (-49.25M). ATNM has more cash in the bank: 59.9M vs. ACHV (55.4M). ATNM has less debt than ACHV: ATNM (1.29M) vs ACHV (9.96M). ACHV (0) and ATNM (0) have equivalent revenues.
ACHVATNMACHV / ATNM
Capitalization260M45.2M575%
EBITDA-49.25M-43.43M113%
Gain YTD29.5458.730338%
P/E RatioN/AN/A-
Revenue00-
Total Cash55.4M59.9M92%
Total Debt9.96M1.29M772%
FUNDAMENTALS RATINGS
ACHV vs ATNM: Fundamental Ratings
ACHV
ATNM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
4077
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACHV's Valuation (53) in the Biotechnology industry is in the same range as ATNM (63). This means that ACHV’s stock grew similarly to ATNM’s over the last 12 months.

ACHV's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that ACHV’s stock grew similarly to ATNM’s over the last 12 months.

ACHV's SMR Rating (99) in the Biotechnology industry is in the same range as ATNM (99). This means that ACHV’s stock grew similarly to ATNM’s over the last 12 months.

ACHV's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for ATNM (77). This means that ACHV’s stock grew somewhat faster than ATNM’s over the last 12 months.

ACHV's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that ACHV’s stock grew similarly to ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHVATNM
RSI
ODDS (%)
Bearish Trend 6 days ago
88%
Bullish Trend 6 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
87%
Bullish Trend 6 days ago
75%
Momentum
ODDS (%)
Bullish Trend 6 days ago
76%
Bullish Trend 6 days ago
80%
MACD
ODDS (%)
Bearish Trend 6 days ago
81%
Bullish Trend 6 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 6 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
74%
Bearish Trend 6 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 8 days ago
71%
Declines
ODDS (%)
Bearish Trend 14 days ago
83%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACHV
Daily Signal:
Gain/Loss:
ATNM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCQEF140.00N/A
N/A
Macquarie Group, Ltd.
TMICF47.79N/A
N/A
Trend Micro Inc.
EXHI0.23N/A
N/A
Exlites Holdings International, Inc.
PMREF10.64N/A
N/A
PRIMARIS REAL ESTATE INV TRUST TR.
NORSF0.14N/A
N/A
NORSK TITANIUM AS

ACHV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with ALT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
-1.94%
ALT - ACHV
46%
Loosely correlated
-3.65%
ATNM - ACHV
37%
Loosely correlated
N/A
PLRX - ACHV
36%
Loosely correlated
-2.61%
CLYM - ACHV
33%
Loosely correlated
-8.38%
ARTV - ACHV
33%
Loosely correlated
-3.75%
More

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with RXRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
N/A
RXRX - ATNM
41%
Loosely correlated
-0.69%
CRBU - ATNM
41%
Loosely correlated
-0.56%
HOWL - ATNM
40%
Loosely correlated
-6.05%
CRSP - ATNM
40%
Loosely correlated
-1.13%
IPSC - ATNM
39%
Loosely correlated
-2.62%
More